Texas Centers for Infectious Disease Associates

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen	HIV-1-infection	Active, not recruiting	Phase 2 / Phase 3	2026-08-10	NCT05502341
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy	HIV-1-infection	Active, not recruiting	Phase 3	2026-06-15	NCT06333808
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1	HIV-1-Infection	Active, not recruiting	Phase 3	2026-05-29	NCT06630299
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1	HIV-1-infection	Active, not recruiting	Phase 3	2026-04-30	NCT06630286
Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed	HIV-1-Infection	Active, not recruiting	Phase 2 / Phase 3	2026-04-17	NCT06544733

Clinical trials